cardiovascular outcomes glp-1 news today The Big Trial of a drug (Wegovy) to Reduce Major Events Can one drug do it

Further research, including the use of male mice, looked at more of the underlying mechanisms that may be involved in this phenomenon, even though the mice were not used in the alcohol intake experiments that the rats were in

The 2025 Cochrane review discussed here evaluated the effectiveness and risks of GLP-1 agonists compared with placebo

Local discomfort or pain: If the vein is inserted or the infusion is administered, local discomfort or pain may occur

Copyright 2025 WTOC

Both intermittent dosing schedules (injections on specific days) and continuous daily administration showed benefits, suggesting some flexibility in protocol design